World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
113
Citations
46120
World Ranking
4964
National Ranking
2695

Psychology

D-Index
112
Citations
45885
World Ranking
368
National Ranking
233

Mauricio Tohen publication distribution in Psychology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Psychology in 2026. The highlighted bar marks where Mauricio Tohen sits on this spectrum.

31–40 publications: 6 scientists 41–50 publications: 52 scientists 51–60 publications: 138 scientists 61–70 publications: 299 scientists 71–80 publications: 461 scientists 81–90 publications: 605 scientists 91–100 publications: 713 scientists 101–110 publications: 736 scientists 111–120 publications: 686 scientists 121–130 publications: 670 scientists 131–140 publications: 644 scientists 141–150 publications: 597 scientists 151–160 publications: 576 scientists 161–170 publications: 477 scientists 171–180 publications: 450 scientists 181–190 publications: 397 scientists 191–200 publications: 343 scientists 201–210 publications: 328 scientists 211–220 publications: 313 scientists 221–230 publications: 283 scientists 231–240 publications: 226 scientists 241–250 publications: 196 scientists 251–260 publications: 201 scientists 261–270 publications: 171 scientists 271–280 publications: 151 scientists 281–290 publications: 139 scientists 291–300 publications: 113 scientists 301–310 publications: 102 scientists 311–320 publications: 100 scientists 321–330 publications: 76 scientists 331–340 publications: 92 scientists 341–350 publications: 85 scientists 351–360 publications: 69 scientists 361–370 publications: 71 scientists 371–380 publications: 63 scientists 381–390 publications: 58 scientists 391–400 publications: 57 scientists 401–410 publications: 43 scientists 411–420 publications: 33 scientists 421–430 publications: 50 scientists 431–440 publications: 41 scientists 441–450 publications: 32 scientists 451–460 publications: 27 scientists 461–470 publications: 28 scientists 471–480 publications: 25 scientists 481–490 publications: 28 scientists 491–500 publications: 20 scientists 501–510 publications: 23 scientists 511–520 publications: 26 scientists 521–530 publications: 17 scientists 531–540 publications: 21 scientists 541–550 publications: 14 scientists 551–560 publications: 16 scientists 561–570 publications: 10 scientists 571–580 publications: 22 scientists 581–590 publications: 9 scientists 591–600 publications: 14 scientists 601–610 publications: 9 scientists 611–620 publications: 11 scientists 621–630 publications: 4 scientists 631–640 publications: 7 scientists 641–650 publications: 5 scientists 651–660 publications: 10 scientists 661–670 publications: 8 scientists 671–680 publications: 8 scientists 681–690 publications: 4 scientists 691–700 publications: 3 scientists 701–704 publications: 4 scientists 705+ publications: 100 scientists
31 publications 705+

This scientist: 523 publications — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 705 publications or more.

Mauricio Tohen D-index placement in Psychology in 2026

The chart shows the D-index (discipline H-index) distribution of Psychology scientists ranked by Research.com in 2026. The highlighted bar marks where Mauricio Tohen sits on this spectrum.

30–31 D-Index: 398 scientists 32–33 D-Index: 702 scientists 34–35 D-Index: 671 scientists 36–37 D-Index: 659 scientists 38–39 D-Index: 641 scientists 40–41 D-Index: 671 scientists 42–43 D-Index: 617 scientists 44–45 D-Index: 558 scientists 46–47 D-Index: 495 scientists 48–49 D-Index: 487 scientists 50–51 D-Index: 445 scientists 52–53 D-Index: 390 scientists 54–55 D-Index: 408 scientists 56–57 D-Index: 345 scientists 58–59 D-Index: 325 scientists 60–61 D-Index: 321 scientists 62–63 D-Index: 248 scientists 64–65 D-Index: 290 scientists 66–67 D-Index: 218 scientists 68–69 D-Index: 219 scientists 70–71 D-Index: 215 scientists 72–73 D-Index: 183 scientists 74–75 D-Index: 169 scientists 76–77 D-Index: 132 scientists 78–79 D-Index: 137 scientists 80–81 D-Index: 120 scientists 82–83 D-Index: 112 scientists 84–85 D-Index: 86 scientists 86–87 D-Index: 101 scientists 88–89 D-Index: 83 scientists 90–91 D-Index: 77 scientists 92–93 D-Index: 70 scientists 94–95 D-Index: 78 scientists 96–97 D-Index: 58 scientists 98–99 D-Index: 53 scientists 100–101 D-Index: 57 scientists 102–103 D-Index: 48 scientists 104–105 D-Index: 53 scientists 106–107 D-Index: 46 scientists 108–109 D-Index: 24 scientists 110–111 D-Index: 35 scientists 112–113 D-Index: 27 scientists 114–115 D-Index: 32 scientists 116–117 D-Index: 31 scientists 118–119 D-Index: 22 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 24 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 11 scientists 128–129 D-Index: 19 scientists 130–131 D-Index: 10 scientists 132–133 D-Index: 16 scientists 134–135 D-Index: 10 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 5 scientists 142–143 D-Index: 12 scientists 144+ D-Index: 98 scientists
30 D-Index 144+

This scientist: 112 D-Index — 97th percentile

97% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 144 D-Index or more.

Overview

Mauricio Tohen is affiliated with the University of New Mexico in the United States. Their research primarily focuses on medicine, with a strong emphasis on psychiatry and mental health. Other areas of study include clinical psychology, pharmacology, radiology, nuclear medicine and imaging, and speech and hearing.

Tohen has contributed extensively to the understanding and treatment of mental health disorders, particularly bipolar disorder and schizophrenia. Key topics in their work encompass bipolar disorder and its treatment, schizophrenia research and treatment, electroconvulsive therapy studies, adolescent and pediatric healthcare, treatment of major depression, tryptophan and brain disorders, and child and adolescent psychosocial and emotional development.

Frequent publication venues for Tohen's research include:

  • Journal of Affective Disorders
  • European Neuropsychopharmacology
  • Bipolar Disorders
  • The Journal of Clinical Psychiatry
  • Community Mental Health Journal

Their notable recent papers are:

  • "Neuroimaging Biomarkers in Schizophrenia" (2021), published in American Journal of Psychiatry
  • "The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review" (2020), published in ClinicoEconomics and Outcomes Research
  • "Lithium treatment of Bipolar disorder in adults: A systematic review of randomized trials and meta-analyses" (2021), published in European Neuropsychopharmacology
  • "Social media recruitment for mental health research: A systematic review" (2020), published in Comprehensive Psychiatry
  • "Preventing new episodes of bipolar disorder in adults: Systematic review and meta-analysis of randomized controlled trials" (2021), published in European Neuropsychopharmacology

Mauricio Tohen collaborates frequently with other researchers active in the field. Regular co-authors include Andrew A. Nierenberg, Terence A. Ketter, Joseph R. Calabrese, Louisa G. Sylvia, and Michael E. Thase.

Best Publications

  • Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

    Mauricio Tohen;Mauricio Tohen;Eduard Vieta;Joseph R Calabrese;Terence A. Ketter

  • Practice guideline for the treatment of patients with schizophrenia

    M. I. Herz;R. P. Liberman;T. H. McGlashan;J. A. Lieberman

  • One hundred years of schizophrenia: a meta-analysis of the outcome literature.

    J D Hegarty;R J Baldessarini;M Tohen;C Waternaux

  • Antipsychotic drug effects on brain morphology in first-episode psychosis

    Jeffrey A. Lieberman;Jeffrey A. Lieberman;Gary D. Tollefson;Cecil Charles;Robert Zipursky

  • Olanzapine Versus Placebo in the Treatment of Acute Mania

    M. Tohen;T. M. Sanger;S. L. Mcelroy;G. D. Tollefson

  • Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study

    Mauricio Tohen;Thomas G. Jacobs;Starr L. Grundy;Susan L. McElroy

  • A novel augmentation strategy for treating resistant major depression.

    Richard C. Shelton;Gary D. Tollefson;Mauricio Tohen;Stephen Stahl

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Outcome in Mania: A 4-Year Prospective Follow-up of 75 Patients Utilizing Survival Analysis

    Mauricio Tohen;Christine M. Waternaux;Ming T. Tsuang

  • Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis.

    Thomas H. McGlashan;Robert B. Zipursky;Diana Perkins;Jean Addington

  • Textbook in psychiatric epidemiology

    Ming T. Tsuang;Mauricio Tohen

  • Two-Year Syndromal and Functional Recovery in 219 Cases of First-Episode Major Affective Disorder With Psychotic Features

    Mauricio Tohen;John Hennen;Carlos M. Zarate;Ross J. Baldessarini

  • The McLean-Harvard first-episode mania study: Prediction of recovery and first recurrence

    Mauricio Tohen;Carlos A. Zarate;John Hennen;Hari Mandir Kaur Khalsa

  • Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

    Mauricio Tohen;Mauricio Tohen;K. N. Roy Chengappa;Trisha Suppes;Carlos A. Zarate

  • Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression

    D. Jeffrey Newport;Linda L. Carpenter;William M. McDonald;James B. Potash

  • The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

    Mauricio Tohen;Mauricio Tohen;Ellen Frank;Charles L. Bowden;Francesc Colom

  • Risk of recurrence following discontinuation of lithium treatment in bipolar disorder.

    Trisha Suppes;Ross J. Baldessarini;Gianni L. Faedda;Mauricio Tohen

  • Comparative Efficacy and Safety of Atypical and Conventional Antipsychotic Drugs in First-Episode Psychosis: A Randomized, Double-Blind Trial of Olanzapine Versus Haloperidol

    Jeffrey A. Lieberman;Gary Tollefson;Mauricio Tohen;Alan I. Green

  • Olanzapine versus lithium in the maintenance treatment of bipolar disorder: a 12-month, randomized, double-blind, controlled clinical trial.

    Mauricio Tohen;Waldemar Greil;Joseph R. Calabrese;Gary S. Sachs

  • Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week study.

    Mauricio Tohen;Terence A. Ketter;Carlos A. Zarate;Trisha Suppes

  • Olanzapine versus placebo in the treatment of acute mania

    Mauricio Tohen;Todd M. Sanger;Gray D. Tollefson

Frequent Co-Authors

Ross J. Baldessarini
Ross J. Baldessarini Harvard University
Eduard Vieta
Eduard Vieta University of Barcelona
Charles L. Bowden
Charles L. Bowden The University of Texas Health Science Center at San Antonio
Terence A. Ketter
Terence A. Ketter Stanford University
Susan L. McElroy
Susan L. McElroy University of Cincinnati Medical Center
Michael E. Thase
Michael E. Thase University of Pennsylvania
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Richard C. Shelton
Richard C. Shelton University of Alabama at Birmingham
Alan Breier
Alan Breier Indiana University
Thilo Deckersbach
Thilo Deckersbach Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a degree in Psychology opens the door to a range of online programs and rewarding career pathways. One popular direction is becoming a licensed school counselor, a role that supports and guides students through educational and personal challenges. Each state in the U.S. has specific educational and certification requirements for these professionals, so it’s important to research your state’s pathway.

For example, the Illinois school counselor education requirements detail the need for accredited coursework and supervised internships. Similarly, those interested in working in Indiana must meet the Indiana school counselor education requirements, which include both academic and experiential components.

In Iowa, aspiring counselors must fulfill the Iowa school counselor education requirements, focusing on graduate degrees and practicum experiences. Those targeting Kansas can review the Kansas school counselor certification requirements for a breakdown of coursework and licensure steps.

Many universities offer online degrees that are tailored to these requirements, allowing you to start your journey toward a rewarding career from anywhere. Be sure to review your state’s guidelines and choose a program that meets the necessary criteria for licensure.

Best Scientists Citing Mauricio Tohen

Trending Scientists